U. Díaz-Aristizabal, M. Valdés-Vilches, T.R. Fernández-Ferreras, E. Calero-Muñoz, E. Bienzobas-Allué, L. Aguilera-Ballester, J. Carnicer-Cáceres
求助PDF
{"title":"A型肉毒杆菌毒素对周围性面神经麻痹后遗症患者功能、联合运动和生活质量的影响。","authors":"U. Díaz-Aristizabal, M. Valdés-Vilches, T.R. Fernández-Ferreras, E. Calero-Muñoz, E. Bienzobas-Allué, L. Aguilera-Ballester, J. Carnicer-Cáceres","doi":"10.1016/j.nrleng.2023.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to assess the effects of botulinum toxin A (BTX-A) infiltration on face muscle function, synkinesis, and quality of life in patients with sequelae of peripheral facial palsy (PFP).</p></div><div><h3>Material and methods</h3><p>We present the results of a prospective study including a sample of 20 patients with sequelae of PFP (15 women, 5 men) who underwent BTX-A (Botox© or Xeomin©) infiltration. All patients had previously received personalised treatment with neuromuscular retraining. A clinical assessment was performed before BTX-A infiltration and 4 weeks after treatment. The effect of BTX-A on face muscle function, quality of life, and synkinesis was evaluated using the Sunnybrook Facial Grading System (SFGS), the Facial Clinimetric Evaluation (FaCE) questionnaire, and the Synkinesis Assessment Questionnaire (SAQ), respectively.</p></div><div><h3>Results</h3><p>Mean SFGS scores increased from 64.8 to 69.9 after BTX-A infiltration (<em>P</em> <!-->=<!--> <!-->.004). Increases were also observed in mean total FaCE scores (from 52.42 to 64.5; <em>P</em> <!--><<!--> <!-->.001) and the mean score on the FaCE social function subscale (from 61.15 to 78.44; <em>P</em> <!--><<!--> <!-->.001). Mean SAQ scores decreased from 46.22 to 37.55 after BTX-A infiltration (<em>P</em> <!-->=<!--> <!-->.001).</p></div><div><h3>Conclusions</h3><p>BTX-A infiltration increases face muscle function, improves quality of life, and reduces synkinesis in patients with sequelae of PFP.</p></div>","PeriodicalId":94155,"journal":{"name":"Neurologia","volume":"38 8","pages":"Pages 560-565"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Effect of botulinum toxin type A in functionality, synkinesis and quality of life in peripheral facial palsy sequelae\",\"authors\":\"U. Díaz-Aristizabal, M. Valdés-Vilches, T.R. Fernández-Ferreras, E. Calero-Muñoz, E. Bienzobas-Allué, L. Aguilera-Ballester, J. Carnicer-Cáceres\",\"doi\":\"10.1016/j.nrleng.2023.07.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>This study aimed to assess the effects of botulinum toxin A (BTX-A) infiltration on face muscle function, synkinesis, and quality of life in patients with sequelae of peripheral facial palsy (PFP).</p></div><div><h3>Material and methods</h3><p>We present the results of a prospective study including a sample of 20 patients with sequelae of PFP (15 women, 5 men) who underwent BTX-A (Botox© or Xeomin©) infiltration. All patients had previously received personalised treatment with neuromuscular retraining. A clinical assessment was performed before BTX-A infiltration and 4 weeks after treatment. The effect of BTX-A on face muscle function, quality of life, and synkinesis was evaluated using the Sunnybrook Facial Grading System (SFGS), the Facial Clinimetric Evaluation (FaCE) questionnaire, and the Synkinesis Assessment Questionnaire (SAQ), respectively.</p></div><div><h3>Results</h3><p>Mean SFGS scores increased from 64.8 to 69.9 after BTX-A infiltration (<em>P</em> <!-->=<!--> <!-->.004). Increases were also observed in mean total FaCE scores (from 52.42 to 64.5; <em>P</em> <!--><<!--> <!-->.001) and the mean score on the FaCE social function subscale (from 61.15 to 78.44; <em>P</em> <!--><<!--> <!-->.001). Mean SAQ scores decreased from 46.22 to 37.55 after BTX-A infiltration (<em>P</em> <!-->=<!--> <!-->.001).</p></div><div><h3>Conclusions</h3><p>BTX-A infiltration increases face muscle function, improves quality of life, and reduces synkinesis in patients with sequelae of PFP.</p></div>\",\"PeriodicalId\":94155,\"journal\":{\"name\":\"Neurologia\",\"volume\":\"38 8\",\"pages\":\"Pages 560-565\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2173580823000421\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2173580823000421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
引用
批量引用
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
